Y-Intercept (Hong Kong) Ltd - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 209 filers reported holding SAGE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Y-Intercept (Hong Kong) Ltd ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$412,553
+34.4%
8,774
+9.0%
0.04%
-2.2%
Q4 2022$307,027
+0.0%
8,050
-13.1%
0.04%
-35.7%
Q1 2022$307,000
-60.9%
9,265
+4.6%
0.07%
-78.9%
Q4 2020$785,0008,8550.33%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders